|
NL6815872A
(https=)
|
1967-11-22 |
1969-05-27 |
|
|
|
JPS5614663B2
(https=)
*
|
1971-08-21 |
1981-04-06 |
|
|
|
US4582833A
(en)
|
1984-04-16 |
1986-04-15 |
American Cyanamid Company |
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
|
|
JPS6130554A
(ja)
|
1984-07-23 |
1986-02-12 |
Ono Pharmaceut Co Ltd |
プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
|
|
US4576943A
(en)
|
1984-10-09 |
1986-03-18 |
American Cyanamid Company |
Pyrazolo[1,5-a]pyrimidines
|
|
DE3608088C2
(de)
|
1986-03-07 |
1995-11-16 |
Schering Ag |
Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
|
|
CA1322197C
(en)
|
1987-07-17 |
1993-09-14 |
Bernd Buchmann |
9-halogen-(z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
|
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
|
US5631401A
(en)
|
1994-02-09 |
1997-05-20 |
Abbott Laboratories |
Inhibitors of protein farnesyltransferase and squalene synthase
|
|
US5585492A
(en)
*
|
1994-10-11 |
1996-12-17 |
G. D. Searle & Co. |
LTA4 Hydrolase inhibitors
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
AU1952597A
(en)
|
1996-02-13 |
1997-09-02 |
G.D. Searle & Co. |
Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
|
|
US5952349A
(en)
*
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
JP2000516611A
(ja)
*
|
1996-08-14 |
2000-12-12 |
ワーナー―ランバート・コンパニー |
Ｍｃｐ―１アンタゴニストとしての２―フェニルベンズイミダゾール誘導体
|
|
NO317155B1
(no)
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
|
KR20000070903A
(ko)
|
1997-02-10 |
2000-11-25 |
오노 야꾸힝 고교 가부시키가이샤 |
11,15-ｏ-디알킬프로스타글란딘 ｅ 유도체, 이것의 제조 방법 및 이것을 유효 성분으로 함유하는 약제
|
|
DE19743435A1
(de)
*
|
1997-10-01 |
1999-04-08 |
Merck Patent Gmbh |
Benzamidinderivate
|
|
US6309561B1
(en)
|
1997-12-24 |
2001-10-30 |
3M Innovative Properties Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
|
US6262293B1
(en)
|
1997-12-25 |
2001-07-17 |
Ono Pharmaceutical Co., Ltd. |
ω-Cycloalkly-prostaglandin e2 derivatives
|
|
US6380203B1
(en)
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
JP4087938B2
(ja)
|
1998-02-04 |
2008-05-21 |
高砂香料工業株式会社 |
ヒノキチオ−ル類の分岐サイクロデキストリン包接化合物からなる抗菌剤およびそれを含有する組成物
|
|
AU757488B2
(en)
|
1998-03-25 |
2003-02-20 |
Bristol-Myers Squibb Company |
Imidazolone anorectic agents: III. heteroaryl derivatives
|
|
GB9815880D0
(en)
|
1998-07-21 |
1998-09-16 |
Pfizer Ltd |
Heterocycles
|
|
US6235780B1
(en)
|
1998-07-21 |
2001-05-22 |
Ono Pharmaceutical Co., Ltd. |
ω-cycloalkyl-prostaglandin E1 derivatives
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US6924313B1
(en)
|
1999-09-23 |
2005-08-02 |
Pfizer Inc. |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
|
|
WO2001056990A2
(en)
|
2000-02-03 |
2001-08-09 |
Eli Lilly And Company |
Pyridine derivates as potentiators of glutamate receptors
|
|
US6451798B2
(en)
|
2000-02-22 |
2002-09-17 |
Cv Therapeutics, Inc. |
Substituted alkyl piperazine derivatives
|
|
US6552023B2
(en)
|
2000-02-22 |
2003-04-22 |
Cv Therapeutics, Inc. |
Aralkyl substituted piperazine compounds
|
|
JP2001354657A
(ja)
|
2000-06-09 |
2001-12-25 |
Sds Biotech:Kk |
置換ピペラジン誘導体及び農園芸用殺菌剤
|
|
EP1170353B1
(en)
|
2000-07-06 |
2005-11-02 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and aligment promoter
|
|
WO2002064211A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
EP1372655B1
(en)
|
2001-03-02 |
2008-10-01 |
Merck Frosst Canada Ltd. |
Cathepsin cysteine protease inhibitors
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
FR2826011B1
(fr)
|
2001-06-14 |
2004-12-10 |
Oreal |
Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
|
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
EP1435946B8
(en)
|
2001-09-14 |
2013-12-18 |
Amgen Inc. |
Linked biaryl compounds
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
EP1693061A1
(en)
|
2002-10-04 |
2006-08-23 |
Ucb, S.A. |
Use of 4-aminoderivatives for the preparation of a medicament for treating neurological diseases
|
|
US7851486B2
(en)
|
2002-10-17 |
2010-12-14 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
|
|
AU2003290527A1
(en)
|
2002-10-17 |
2004-05-04 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction
|
|
WO2004058683A2
(en)
|
2002-12-20 |
2004-07-15 |
Migenix Corp. |
Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
|
|
WO2004089410A1
(ja)
|
2003-04-03 |
2004-10-21 |
Kyowa Hakko Kogyo Co., Ltd. |
神経因性疼痛の予防及び／または治療剤
|
|
WO2004099164A1
(en)
|
2003-05-02 |
2004-11-18 |
Rigel Pharmaceuticals, Inc. |
Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
|
|
JP2005008581A
(ja)
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
CN1856490A
(zh)
|
2003-07-28 |
2006-11-01 |
詹森药业有限公司 |
苯并咪唑、苯并噻唑和苯并噁唑衍生物及其作为lta4h调节剂的应用
|
|
US20050272051A1
(en)
|
2003-09-17 |
2005-12-08 |
Decode Genetics Ehf. |
Methods of preventing or treating recurrence of myocardial infarction
|
|
WO2005033079A1
(ja)
|
2003-09-30 |
2005-04-14 |
Eisai Co., Ltd. |
ヘテロ環化合物を含有する新規な抗真菌剤
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10356579A1
(de)
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
WO2005066238A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Medicinal compositions and method for the preparation thereof
|
|
DE602005015682D1
(de)
|
2004-02-04 |
2009-09-10 |
Neurosearch As |
Dimere azacyclische verbindungen und deren verwendung
|
|
WO2006033795A2
(en)
|
2004-09-17 |
2006-03-30 |
Wyeth |
Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
|
|
ES2570332T3
(es)
|
2005-03-16 |
2016-05-17 |
Meda Pharma Gmbh & Co Kg |
La combinación de anticolinérgicos y antagonistas del receptor de leucotrieno para el tratamiento de enfermedades respiratorias
|
|
US20060223792A1
(en)
|
2005-03-31 |
2006-10-05 |
Butler Christopher R |
Phenyl and pyridyl LTA4H modulators
|
|
JP2008540395A
(ja)
|
2005-05-03 |
2008-11-20 |
ファイザー・インク |
アミドレソルシノール化合物
|
|
WO2006130075A1
(en)
|
2005-05-31 |
2006-12-07 |
Astrazeneca Ab |
Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders
|
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
US20070078263A1
(en)
*
|
2005-09-21 |
2007-04-05 |
Decode Chemistry, Inc. |
Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007079078A1
(en)
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
WO2007079003A2
(en)
*
|
2005-12-29 |
2007-07-12 |
Bayer Schering Pharma Aktiengesellschaft |
Amide inhibitors of leukotriene a4 hydrolase
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
US20100029619A1
(en)
|
2006-08-04 |
2010-02-04 |
Takeda Pharmaceutical Company Limted |
Fused heterocyclic compound
|
|
JP5167265B2
(ja)
*
|
2006-10-19 |
2013-03-21 |
エフ．ホフマン−ラ ロシュ アーゲー |
微量アミン関連受容体に親和性を有するアミノメチル−２−イミダゾール
|
|
JP5219465B2
(ja)
*
|
2006-11-10 |
2013-06-26 |
大塚製薬株式会社 |
医薬
|
|
HRP20170621T1
(hr)
|
2006-12-14 |
2017-07-28 |
Janssen Pharmaceutica N.V. |
Postupak za pripremanje derivata piperazinil i diazepanil benzamida
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
CN101687844B
(zh)
|
2007-07-02 |
2013-11-13 |
弗·哈夫曼-拉罗切有限公司 |
用作ccr2受体拮抗剂的咪唑衍生物
|
|
AU2008285795A1
(en)
|
2007-08-03 |
2009-02-12 |
F. Hoffmann-La Roche Ag |
Pyridinecarboxamide and benzamide derivatives as TAAR1 ligands
|
|
AR068498A1
(es)
|
2007-09-27 |
2009-11-18 |
Merck & Co Inc |
Compuestos de oxadiazol para inhibicion de biosintesis de leucotrienos
|
|
WO2009074829A1
(en)
|
2007-12-12 |
2009-06-18 |
Astrazeneca Ab |
Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
|
|
US20110009429A1
(en)
|
2008-02-26 |
2011-01-13 |
Paul Oakley |
Heterocyclic compounds as inhibitors of cxcr2
|
|
FR2928070A1
(fr)
|
2008-02-27 |
2009-09-04 |
Sumitomo Chemical Co |
Composition agricole, utilisation d'un compose pour sa production et procede pour matriser ou prevenir les maladies des plantes.
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
SI2336125T1
(sl)
|
2008-04-11 |
2013-04-30 |
Janssen Pharmaceutica N.V. |
Tiazolopiridin-2-iloksi-fenil in tiazolopirazin-2-iloksi-fenil amini kot modulatorji levkotrien a4 hidrolaze
|
|
EP2110374A1
(en)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
|
WO2010011912A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Trpv4 antagonists
|
|
ES2399179T3
(es)
|
2008-08-07 |
2013-03-26 |
Pulmagen Therapeutics (Inflammation) Limited |
Tratamiento de enfermedad respiratoria
|
|
RU2589823C2
(ru)
|
2009-04-09 |
2016-07-10 |
Алкермес Фарма Айэленд Лимитед |
Композиция для доставки лекарственных средств
|
|
CN102030700B
(zh)
|
2009-09-30 |
2016-06-01 |
中国医学科学院药物研究所 |
苯甲酰胺基羧酸类化合物及其制法和药物用途
|
|
JP5781527B2
(ja)
*
|
2009-10-30 |
2015-09-24 |
ヤンセン ファーマシューティカ エヌ．ベー． |
４−置換−２−フェノキシ−フェニルアミンデルオピオイド受容体調節因子
|
|
PH12012501068A1
(en)
|
2009-12-07 |
2013-02-04 |
Targacept Inc |
3,6-diazabicyclo [3.1.1] heptanes as neuronal nicotinic acetylcholine receptor ligands
|
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
|
BR112013002112B1
(pt)
*
|
2010-07-29 |
2021-04-06 |
Rigel Pharmaceuticals, Inc. |
Composto, composição farmacêutica, e, uso de um composto, ou de um respectivo sal farmaceuticamente aceitável, ou de uma composição
|
|
WO2012067822A1
(en)
|
2010-11-16 |
2012-05-24 |
Abbott Laboratories |
Pyrazolo [1, 5 -a] pyrimidin potassium channel modulators
|
|
CA2835617C
(en)
|
2011-03-14 |
2020-07-21 |
Boehringer Ingelheim International Gmbh |
Benzodioxane inhibitors of leukotriene production
|
|
PH12013501882A1
(en)
|
2011-03-15 |
2013-10-14 |
Rib X Pharmaceuticals Inc |
Antimicrobial agents
|
|
KR101862291B1
(ko)
|
2011-04-12 |
2018-05-29 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
|
|
WO2012162407A1
(en)
|
2011-05-23 |
2012-11-29 |
Janssen Pharmaceutica Nv |
Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
|
|
CN103159742B
(zh)
*
|
2011-12-16 |
2015-08-12 |
北京韩美药品有限公司 |
5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
|
|
US9006235B2
(en)
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
US9233089B2
(en)
|
2012-03-23 |
2016-01-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of pulmonary hypertension with leukotriene inhibitors
|
|
ES2864862T3
(es)
*
|
2013-03-12 |
2021-10-14 |
Celltaxis Llc |
Métodos de inhibición de la leucotrieno A4 hidrolasa
|
|
MX2015011677A
(es)
|
2013-03-14 |
2016-07-08 |
Celtaxsys Inc |
Inhibidores de leucotrieno a4 hidrolasa.
|
|
WO2014152536A2
(en)
*
|
2013-03-14 |
2014-09-25 |
Celtaxsys, Inc. |
Inhibitors of leukotriene a4 hydrolase
|
|
RU2678196C2
(ru)
*
|
2013-03-14 |
2019-01-24 |
Селтакссис, Инк. |
Производные 2-фениламино-3-цианопиразоло[1,5-а]пиримидина, полезные в качестве ингибитора лейкотриен-a4-гидролазы
|